Objectives To perform a systematic literature review (SLR) concerning the safety of synthetic
(s) and biological (b) disease-modifying anti rheumatic dugs (DMARDs) to inform the 2019 …

Objectives Informing an international task force updating the consensus statement on
efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) …

Introduction: Despite the therapeutic effectiveness of biologics targeting immune cells or
cytokines in patients with inflammatory arthritis, which reflects their pathogenic roles, an …

The current treatment approach in rheumatoid arthritis (RA) follows a stepwise management,
starting from early introduction of conventional synthetic (cs) disease-modifying anti …

Aims This retrospective cohort study aimed to evaluate the effect of the interaction between
methotrexate and glucocorticoids on the risk of developing bacterial infections in patients …

To estimate biologic influence on heart failure (HF) risk in rheumatoid arthritis. Retrospective
cohort (RECORD Study of Italian Society for Rheumatology) study on administrative …

Introduction More than 15 years after its introduction, there is still no agreement as to
whether anti-TNF treatment increases the risk of developing infections, cardiovascular or …

Objective. To examine changes in prescribing patterns, especially the use of corticosteroids
(CS), in patients with rheumatoid arthritis (RA) over 2 decades. Methods. This was a …

Objective: The objective of this review was to estimate the population-based incidence and
determine the types of severe infection and deaths experienced by patients with rheumatoid …

Objectives To evaluate the effectiveness and safety of abatacept over 52 weeks in biologic-
naïve rheumatoid arthritis (RA) patients with moderate disease activity in the prospective, 5 …